Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults

Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958

NCT00995826 ·Status: COMPLETED ·Phase: PHASE1

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

NCT04956575 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

NCT00125944 ·Status: COMPLETED ·Phase: PHASE3

Influenza Antiviral DAS-181-F04 in Healthy Adults

NCT01651494 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety of H1N1 Monovalent Vaccine (MEDI3414) in Healthy Adults

NCT00945893 ·Status: COMPLETED ·Phase: PHASE4

H7N9 Boost in Healthy Adults

NCT02586792 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects

NCT03345043 ·Status: COMPLETED ·Phase: PHASE1

BPL-1357 Against H1N1 Influenza Virus Challenge

NCT07215858 ·Status: RECRUITING ·Phase: PHASE2

Influenza Viral Challenge Study of CC-42344 in Healthy Participants

NCT06160531 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Assess the Safety of a New Influenza Vaccine

NCT01104493 ·Status: COMPLETED ·Phase: PHASE4

Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg

NCT05569239 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine

NCT03450915 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

NCT00989287 ·Status: COMPLETED ·Phase: PHASE3

INNA-051 Influenza Challenge Study

NCT05255822 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

NCT00845429 ·Status: COMPLETED ·Phase: PHASE2

Influenza Antiviral DAS181-F03

NCT01173224 ·Status: COMPLETED ·Phase: PHASE1

Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain

NCT02423577 ·Status: COMPLETED ·Phase: PHASE2

Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza

NCT01037205 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

NCT00968526 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers

NCT02822105 ·Status: COMPLETED ·Phase: PHASE1

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

NCT06382311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX

NCT03232567 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

NCT05027932 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

NCT07121192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

NCT05827978 ·Status: COMPLETED ·Phase: PHASE3